Skip to main content
. Author manuscript; available in PMC: 2016 Jun 13.
Published in final edited form as: Invest New Drugs. 2008 Apr 19;26(4):331–338. doi: 10.1007/s10637-008-9129-0

Fig. 1.

Fig. 1

XK469R induced myelosuppression at all dose levels. Reliable and reversible myelosuppression was induced by XK469R at all dose levels (color coded) with a median time to WBC count nadir (Y-axis) of 12 days (range, 4–21). The median time to WBC count recovery (to baseline or normalization) was 23.5 days (range, 9–53)